165 related articles for article (PubMed ID: 14764825)
1. Expression, localization, and signaling of prostaglandin F2 alpha receptor in human endometrial adenocarcinoma: regulation of proliferation by activation of the epidermal growth factor receptor and mitogen-activated protein kinase signaling pathways.
Sales KJ; Milne SA; Williams AR; Anderson RA; Jabbour HN
J Clin Endocrinol Metab; 2004 Feb; 89(2):986-93. PubMed ID: 14764825
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin (PG) F(2alpha) receptor expression and signaling in human endometrium: role of PGF(2alpha) in epithelial cell proliferation.
Milne SA; Jabbour HN
J Clin Endocrinol Metab; 2003 Apr; 88(4):1825-32. PubMed ID: 12679480
[TBL] [Abstract][Full Text] [Related]
3. F-prostanoid receptor regulation of fibroblast growth factor 2 signaling in endometrial adenocarcinoma cells.
Sales KJ; Boddy SC; Williams AR; Anderson RA; Jabbour HN
Endocrinology; 2007 Aug; 148(8):3635-44. PubMed ID: 17478553
[TBL] [Abstract][Full Text] [Related]
4. A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas.
Sales KJ; List T; Boddy SC; Williams AR; Anderson RA; Naor Z; Jabbour HN
Cancer Res; 2005 Sep; 65(17):7707-16. PubMed ID: 16140938
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin F2alpha-F-prostanoid receptor signaling promotes neutrophil chemotaxis via chemokine (C-X-C motif) ligand 1 in endometrial adenocarcinoma.
Wallace AE; Sales KJ; Catalano RD; Anderson RA; Williams AR; Wilson MR; Schwarze J; Wang H; Rossi AG; Jabbour HN
Cancer Res; 2009 Jul; 69(14):5726-33. PubMed ID: 19549892
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 and F2alpha activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element.
Sales KJ; Grant V; Jabbour HN
Mol Cell Endocrinol; 2008 Mar; 285(1-2):51-61. PubMed ID: 18316157
[TBL] [Abstract][Full Text] [Related]
7. A positive feedback loop that regulates cyclooxygenase-2 expression and prostaglandin F2alpha synthesis via the F-series-prostanoid receptor and extracellular signal-regulated kinase 1/2 signaling pathway.
Jabbour HN; Sales KJ; Boddy SC; Anderson RA; Williams AR
Endocrinology; 2005 Nov; 146(11):4657-64. PubMed ID: 16081631
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin F(2alpha)-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway.
Sales KJ; Maldonado-Pérez D; Grant V; Catalano RD; Wilson MR; Brown P; Williams AR; Anderson RA; Thompson EA; Jabbour HN
Biochim Biophys Acta; 2009 Dec; 1793(12):1917-28. PubMed ID: 19819266
[TBL] [Abstract][Full Text] [Related]
9. Chemokine (C-C) motif ligand 20 is regulated by PGF(2α)-F-prostanoid receptor signalling in endometrial adenocarcinoma and promotes cell proliferation.
Wallace AE; Catalano RD; Anderson RA; Jabbour HN
Mol Cell Endocrinol; 2011 Jan; 331(1):129-35. PubMed ID: 20816914
[TBL] [Abstract][Full Text] [Related]
10. PGF2α-F-prostanoid receptor signalling via ADAMTS1 modulates epithelial cell invasion and endothelial cell function in endometrial cancer.
Keightley MC; Sales KJ; Jabbour HN
BMC Cancer; 2010 Sep; 10():488. PubMed ID: 20840749
[TBL] [Abstract][Full Text] [Related]
11. F-Prostaglandin receptor regulates endothelial cell function via fibroblast growth factor-2.
Keightley MC; Brown P; Jabbour HN; Sales KJ
BMC Cell Biol; 2010 Jan; 11():8. PubMed ID: 20092633
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-11 in endometrial adenocarcinoma is regulated by prostaglandin F2alpha-F-prostanoid receptor interaction via the calcium-calcineurin-nuclear factor of activated T cells pathway and negatively regulated by the regulator of calcineurin-1.
Sales KJ; Grant V; Cook IH; Maldonado-Pérez D; Anderson RA; Williams AR; Jabbour HN
Am J Pathol; 2010 Jan; 176(1):435-45. PubMed ID: 20008143
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor is an obligatory intermediate for oxytocin-induced cyclooxygenase 2 expression and prostaglandin F2 alpha production in bovine endometrial epithelial cells.
Krishnaswamy N; Lacroix-Pepin N; Chapdelaine P; Taniguchi H; Kauffenstein G; Chakravarti A; Danyod G; Fortier MA
Endocrinology; 2010 Mar; 151(3):1367-74. PubMed ID: 20080869
[TBL] [Abstract][Full Text] [Related]
14. Elevated prostaglandin EP2 receptor in endometrial adenocarcinoma cells promotes vascular endothelial growth factor expression via cyclic 3',5'-adenosine monophosphate-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase 1/2 signaling pathways.
Sales KJ; Maudsley S; Jabbour HN
Mol Endocrinol; 2004 Jun; 18(6):1533-45. PubMed ID: 15044590
[TBL] [Abstract][Full Text] [Related]
15. Seminal plasma and prostaglandin E2 up-regulate fibroblast growth factor 2 expression in endometrial adenocarcinoma cells via E-series prostanoid-2 receptor-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase pathway.
Battersby S; Sales KJ; Williams AR; Anderson RA; Gardner S; Jabbour HN
Hum Reprod; 2007 Jan; 22(1):36-44. PubMed ID: 16905765
[TBL] [Abstract][Full Text] [Related]
16. F-prostanoid receptor alters adhesion, morphology and migration of endometrial adenocarcinoma cells.
Sales KJ; Boddy SC; Jabbour HN
Oncogene; 2008 Apr; 27(17):2466-77. PubMed ID: 17968320
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 mediates phosphorylation and down-regulation of the tuberous sclerosis-2 tumor suppressor (tuberin) in human endometrial adenocarcinoma cells via the Akt signaling pathway.
Sales KJ; Battersby S; Williams AR; Anderson RA; Jabbour HN
J Clin Endocrinol Metab; 2004 Dec; 89(12):6112-8. PubMed ID: 15579767
[TBL] [Abstract][Full Text] [Related]
18. EP2 receptor mediated cAMP release is augmented by PGF 2 alpha activation of the FP receptor via the calcium-calmodulin pathway.
Abera AB; Sales KJ; Catalano RD; Katz AA; Jabbour HN
Cell Signal; 2010 Jan; 22(1):71-9. PubMed ID: 19782748
[TBL] [Abstract][Full Text] [Related]
19. Biasing the prostaglandin F2α receptor responses toward EGFR-dependent transactivation of MAPK.
Goupil E; Wisehart V; Khoury E; Zimmerman B; Jaffal S; Hébert TE; Laporte SA
Mol Endocrinol; 2012 Jul; 26(7):1189-202. PubMed ID: 22638073
[TBL] [Abstract][Full Text] [Related]
20. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
Liu Z; Qi S; Zhao X; Li M; Ding S; Lu J; Zhang H
Oncotarget; 2016 Apr; 7(16):21315-31. PubMed ID: 26824324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
